Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion type Assertion NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_head.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion description "[When TM expression was compared between the primary and metastatic lesions in the 36 patients who had lymph node metastasis, 14 (39%) showed decreased TM expression, 19 (53%) showed no change, and 3 (8%) showed an increase in the metastatic lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion evidence source_evidence_literature NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion SIO_000772 9234185 NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion wasDerivedFrom befree-20140225 NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.
- NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_assertion wasGeneratedBy ECO_0000203 NP635039.RAOrlxJH4xbeARXtuqWn9jOp-UvoGA9jzaiKKPX5RfGvg130_provenance.